Literature DB >> 4877993

Kinins--possible physiologic and pathologic roles in man.

R W Kellermeyer, R C Graham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4877993     DOI: 10.1056/NEJM196810172791605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Editorial: Diagnosis of malignant carcinoid syndrome.

Authors: 
Journal:  Br Med J       Date:  1975-07-19

2.  Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia.

Authors:  S A Stalcup; J S Lipset; J M Woan; P Leuenberger; R B Mellins
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

3.  Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.

Authors:  H Weidenbach; M M Lerch; T M Gress; D Pfaff; S Turi; G Adler
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Hyperkinetic shock in viral and pneumococcal pneumonias.

Authors:  J Dussan; B Regnier; T Darragon; B Teisseire; J R Le Gall; F Lemaire
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

Review 5.  Review of the toxicology of beclomethasone dipropionate.

Authors:  S E Libretto
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  An Extensive Study of the Functional Polymorphisms of Kinin-Kallikrein System in Rheumatoid Arthritis Susceptibility.

Authors:  Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

7.  The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma.

Authors:  R W Kellermeyer; K S Warren
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

8.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.